Machine learning models for estimating counterfactuals in a single-arm inflammatory bowel disease study

• URL: http://arxiv.org/abs/2604.23465v1
• Date: Sat, 25 Apr 2026 23:09:07 GMT
• Title: Machine learning models for estimating counterfactuals in a single-arm inflammatory bowel disease study
• Abstract summary: Single-arm trials accelerate study timelines by reducing the number of patients that must be recruited for a concurrent control group.<n>One approach is to construct a virtual control arm using a machine learning (ML) model trained on external control data to predict the counterfactual outcomes of the treatment arm.<n>Our study supports virtual controls as a viable and effective substitute for expensive, lengthy or unethical patient recruitment in an inflammatory bowel disease (IBD) trial.
• Score: 1.685177132716279
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: Single-arm trials accelerate study timelines by reducing the number of patients that must be recruited for a concurrent control group. However, these designs require an alternative comparator to estimate treatment effects. One approach is to construct a virtual control arm using a machine learning (ML) model trained on external control data to predict the counterfactual outcomes of the treatment arm. Our aim in this study was to leverage virtual controls by developing and evaluating ML-based counterfactual outcome models trained on IFX-treated patients to predict 1-year steroid-free clinical remission (SFCR ) and a composite of C-reactive protein remission plus steroid-free clinical remission (CRP-SFCR) for ADA-treated pediatric Crohn's disease patients, and to compare the resulting IFX-versus-ADA treatment effect estimates with those obtained using propensity score matching to external controls. Five ML models were used to train counterfactual models on the observed IFX cohort data. The resulting models were used to predict the counterfactual outcomes for the ADA arm patients. LGBM yields the best OR closest to the propensity score matched reference, and all 95% CI results align with the conclusion from the reference study that no statistical difference in the primary and secondary outcomes has been observed between the patients treated with ADA or IFX. Our study supports virtual controls as a viable and effective substitute for expensive, lengthy or unethical patient recruitment in an inflammatory bowel disease (IBD) trial. The developed gradient boosted prediction model can be used as a pretrained model to generate IFX counterfactual predictions in future studies, pending external validation and assessment of transportability.

Related papers

• Estimating Individualized Treatment Effects in Acute Ischemic Stroke with Causal Transformation Models (TRAM-DAG): A Multi-Centre Observational Study with External RCT Validation [0.5359378066251386]
  Mechanical thrombectomy has been shown to be more effective on average than lysis in randomized controlled trials (RCTs)<n>We aim to identify which individual patients benefit most from mechanical thrombectomy compared to lysis.<n>We demonstrate that causal transformation models on directed acyclic graphs (TRAM-DAG) can be used for ITE estimation after being fitted on observational stroke patient data.
  arXiv  Detail & Related papers  (2026-06-10T19:29:43Z)
• Digital Twins as Synthetic Controls in Single-Arm Trials [0.0]
  We argue that outcome-model-based synthetic control arms are an important tool for single-arm trials.<n>We focus on digital twins, personalized predictions of disease progression generated from machine learning models trained on historical datasets.
  arXiv  Detail & Related papers  (2026-05-12T23:58:48Z)
• Predicting Neuromodulation Outcome for Parkinson's Disease with Generative Virtual Brain Model [95.41752463487008]
  Parkinson's disease affects over ten million people worldwide.<n>Inter-individual variability limits empirical treatment selection, increasing non-negligible surgical risk and cost.<n>We bridge this gap with a pretraining-finetuning framework to predict outcomes directly from resting-state fMRI.
  arXiv  Detail & Related papers  (2026-03-31T02:36:10Z)
• Investigating the Impact of Histopathological Foundation Models on Regressive Prediction of Homologous Recombination Deficiency [52.50039435394964]
  We systematically evaluate foundation models for regression-based tasks.<n>We extract patch-level features from whole slide images (WSI) using five state-of-the-art foundation models.<n>Models are trained to predict continuous HRD scores based on these extracted features across breast, endometrial, and lung cancer cohorts.
  arXiv  Detail & Related papers  (2026-01-29T14:06:50Z)
• The Framework That Survives Bad Models: Human-AI Collaboration For Clinical Trials [2.6377299508948746]
  Using AI as a supporting reader (AI-SR) is the most suitable approach for clinical trials, as it meets all criteria across various model types, even with bad models.<n>This method consistently provides reliable disease estimation, preserves clinical trial treatment effect estimates and conclusions, and retains these advantages when applied to different populations.
  arXiv  Detail & Related papers  (2025-10-08T01:40:41Z)
• A novel language model for predicting serious adverse event results in clinical trials from their prospective registrations [8.134674449860668]
  We evaluated methods for predicting serious adverse event (SAE) results in clinical trials using information only from their registrations prior to the trial.<n>We analyzed 22,107 two-arm parallel interventional clinical trials from ClinicalTrials.gov with structured summary results.
  arXiv  Detail & Related papers  (2025-07-21T07:56:06Z)
• Using Pre-training and Interaction Modeling for ancestry-specific disease prediction in UK Biobank [69.90493129893112]
  Recent genome-wide association studies (GWAS) have uncovered the genetic basis of complex traits, but show an under-representation of non-European descent individuals. Here, we assess whether we can improve disease prediction across diverse ancestries using multiomic data.
  arXiv  Detail & Related papers  (2024-04-26T16:39:50Z)
• Prediction of drug effectiveness in rheumatoid arthritis patients based on machine learning algorithms [2.5759046095742453]
  Rheumatoid arthritis (RA) is an autoimmune condition caused when patients' immune system mistakenly targets their own tissue. Machine learning (ML) has the potential to identify patterns in patient electronic health records to forecast the best clinical treatment to improve patient outcomes. This study introduced a Drug Response Prediction (TNF) framework with two main goals: 1) design a data processing pipeline to extract information from clinical data, and then preprocess it for functional use, and 2) predict RA patient's responses to drugs and evaluate classification models' performance.
  arXiv  Detail & Related papers  (2022-10-14T15:15:37Z)
• Bayesian prognostic covariate adjustment [59.75318183140857]
  Historical data about disease outcomes can be integrated into the analysis of clinical trials in many ways. We build on existing literature that uses prognostic scores from a predictive model to increase the efficiency of treatment effect estimates.
  arXiv  Detail & Related papers  (2020-12-24T05:19:03Z)
• Increasing the efficiency of randomized trial estimates via linear adjustment for a prognostic score [59.75318183140857]
  Estimating causal effects from randomized experiments is central to clinical research. Most methods for historical borrowing achieve reductions in variance by sacrificing strict type-I error rate control.
  arXiv  Detail & Related papers  (2020-12-17T21:10:10Z)
• MIA-Prognosis: A Deep Learning Framework to Predict Therapy Response [58.0291320452122]
  This paper aims at a unified deep learning approach to predict patient prognosis and therapy response. We formalize the prognosis modeling as a multi-modal asynchronous time series classification task. Our predictive model could further stratify low-risk and high-risk patients in terms of long-term survival.
  arXiv  Detail & Related papers  (2020-10-08T15:30:17Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.